217 related articles for article (PubMed ID: 31842528)
1. Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea.
Park E; Lee Y; Jue MS
Korean J Intern Med; 2020 Jul; 35(4):917-928. PubMed ID: 31842528
[TBL] [Abstract][Full Text] [Related]
2. Is there a Link between Non Melanoma Skin Cancer and Hydrochlorothiazide?
Gallelli L; Cione E; Siniscalchi A; Vasta G; Guerra A; Scaramuzzino A; Longo L; Muraca L; De Sarro G; G Sp Working Group ; Leuzzi G; Gerace A; Scuteri A; Vasapollo P; Natale V; Zampogna S; Luciani F
Curr Drug Saf; 2022; 17(3):211-216. PubMed ID: 34732119
[TBL] [Abstract][Full Text] [Related]
3. Use of hydrochlorothiazide and risk of nonmelanoma skin cancer in Koreans: a retrospective cohort study using administrative healthcare data.
Kim JC; Kim YC; Choi JW
Clin Exp Dermatol; 2021 Jun; 46(4):680-686. PubMed ID: 33215728
[TBL] [Abstract][Full Text] [Related]
4. Risk of Nonmelanoma Skin Cancer in Association With Use of Hydrochlorothiazide-Containing Products in the United States.
Eworuke E; Haug N; Bradley M; Cosgrove A; Zhang T; Dee EC; Adimadhyam S; Petrone A; Lee H; Woodworth T; Toh S
JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 33733052
[TBL] [Abstract][Full Text] [Related]
5. Does hydrochlorothiazide increase the incidence of skin, lip and oral cancer in a UK population?
Carney K; Cousins M
Evid Based Dent; 2022 Mar; 23(1):38-39. PubMed ID: 35338330
[TBL] [Abstract][Full Text] [Related]
6. Importance of accounting for timing of time-varying exposures in association studies: Hydrochlorothiazide and non-melanoma skin cancer.
Danieli C; Moura CS; Pilote L; Bernatsky S; Abrahamowicz M
Pharmacoepidemiol Drug Saf; 2023 Dec; 32(12):1411-1420. PubMed ID: 37528702
[TBL] [Abstract][Full Text] [Related]
7. Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study.
Pottegård A; Pedersen SA; Schmidt SAJ; Lee CN; Hsu CK; Liao TC; Shao SC; Lai EC
Br J Cancer; 2019 Nov; 121(11):973-978. PubMed ID: 31673105
[TBL] [Abstract][Full Text] [Related]
8. The effect of hydrochlorothiazide on the recurrence of nonmelanoma skin cancer: a 7-year retrospective study comprising 300 patients.
Özkan B; Savran S; Akıncı K; Albayati A; Uysal Pİ; Uysal AÇ
Turk J Med Sci; 2023 Jun; 53(3):760-752. PubMed ID: 37476909
[TBL] [Abstract][Full Text] [Related]
9. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark.
Pedersen SA; Gaist D; Schmidt SAJ; Hölmich LR; Friis S; Pottegård A
J Am Acad Dermatol; 2018 Apr; 78(4):673-681.e9. PubMed ID: 29217346
[TBL] [Abstract][Full Text] [Related]
10. Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multisite population-based cohort study.
Azoulay L; St-Jean A; Dahl M; Quail J; Aibibula W; Brophy JM; Chan AW; Bresee L; Carney G; Eltonsy S; Tamim H; Paterson JM; Platt RW;
J Am Acad Dermatol; 2023 Aug; 89(2):243-253. PubMed ID: 37105517
[TBL] [Abstract][Full Text] [Related]
11. Association between Use of Hydrochlorothiazide and Nonmelanoma Skin Cancer: Common Data Model Cohort Study in Asian Population.
Lee SM; Kim K; Yoon J; Park SK; Moon S; Lee SE; Oh J; Yoo S; Kim KI; Yoon HJ; Lee HY
J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32916988
[TBL] [Abstract][Full Text] [Related]
12. The association between hydrochlorothiazide use and non-melanoma skin cancer in kidney transplant recipients.
Rahamimov R; Telem S; Davidovichi B; Bielopolski D; Steinmetz T; Nesher E; Lichtenberg S; Rozen-Zvi B
Clin Kidney J; 2024 May; 17(5):sfae126. PubMed ID: 38812910
[TBL] [Abstract][Full Text] [Related]
13. The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea.
Kim HS; Kim HJ; Hong ES; Kim KB; Lee JD; Kang TU; Ahn HS
Br J Dermatol; 2020 Apr; 182(4):907-915. PubMed ID: 31233609
[TBL] [Abstract][Full Text] [Related]
14. Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer.
Rouette J; Yin H; Pottegård A; Nirantharakumar K; Azoulay L
Drug Saf; 2021 Feb; 44(2):245-254. PubMed ID: 33104975
[TBL] [Abstract][Full Text] [Related]
15. Associations of thiazide use with skin cancers: a systematic review and meta-analysis.
Shao SC; Lai CC; Chen YH; Lai EC; Hung MJ; Chi CC
BMC Med; 2022 Jul; 20(1):228. PubMed ID: 35794547
[TBL] [Abstract][Full Text] [Related]
16. Association between hydrochlorothiazide and the risk of in situ and invasive squamous cell skin carcinoma and basal cell carcinoma: A population-based case-control study.
Adalsteinsson JA; Muzumdar S; Waldman R; Hu C; Wu R; Ratner D; Ungar J; Silverberg JI; Olafsdottir GH; Kristjansson AK; Tryggvadottir L; Jonasson JG
J Am Acad Dermatol; 2021 Mar; 84(3):669-675. PubMed ID: 32791082
[TBL] [Abstract][Full Text] [Related]
17. Risk of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide: A population-based case-control study.
Daniels B; Pearson SA; Vajdic CM; Pottegård A; Buckley NA; Zoega H
Basic Clin Pharmacol Toxicol; 2020 Oct; 127(4):320-328. PubMed ID: 32608576
[TBL] [Abstract][Full Text] [Related]
18. Use of hydrochlorothiazide and risk of skin cancer in a large nested case-control study in Spain.
León-Muñoz LM; Duarte-Salles T; Llorente A; Díaz Y; Puente D; Pottegård A; Montero-Corominas D; Huerta C
Pharmacoepidemiol Drug Saf; 2021 Sep; 30(9):1269-1278. PubMed ID: 34015159
[TBL] [Abstract][Full Text] [Related]
19. Hydrochlorothiazide use, sun exposure, and risk of keratinocyte cancer.
VanWormer JJ; Abokede EB; Berg RL
BMC Public Health; 2022 Jul; 22(1):1282. PubMed ID: 35780087
[TBL] [Abstract][Full Text] [Related]
20. Non-melanoma skin cancer as a clinical marker for internal malignancies: a nationwide population-based cohort study.
Yun SJ; Bae JM; Kim H; Park BC; Kim JS; Seo SH; Ahn HH; Lee DY; Kim YC; Park HJ; Chung KY
J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):746-753. PubMed ID: 31494979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
